OpenDose: Open-Access Resource for Nuclear Medicine Dosimetry.


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
10 2020
Historique:
received: 02 12 2019
accepted: 26 02 2020
pubmed: 15 3 2020
medline: 10 3 2021
entrez: 15 3 2020
Statut: ppublish

Résumé

Radiopharmaceutical dosimetry depends on the localization in space and time of radioactive sources and requires the estimation of the amount of energy emitted by the sources deposited within targets. In particular, when computing resources are not accessible, this task can be performed using precomputed tables of specific absorbed fractions (SAFs) or S values based on dosimetric models. The aim of the OpenDose collaboration is to generate and make freely available a range of dosimetric data and tools.

Identifiants

pubmed: 32169912
pii: jnumed.119.240366
doi: 10.2967/jnumed.119.240366
pmc: PMC7539649
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1514-1519

Informations de copyright

© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Ann ICRP. 2007;37(2-4):1-332
pubmed: 18082557
Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2456-2474
pubmed: 30218316
Phys Med Biol. 2014 Sep 21;59(18):R233-302
pubmed: 25144730
EJNMMI Res. 2017 Nov 3;7(1):88
pubmed: 29098485
Ann ICRP. 2008;38(3):7-96
pubmed: 19285593
Ann ICRP. 2018 Oct;47(3-4):45-62
pubmed: 29651869
Med Phys. 2014 Jun;41(6):064301
pubmed: 24877844
EJNMMI Phys. 2017 Nov 21;4(1):27
pubmed: 29164483
Med Phys. 2002 Dec;29(12):2745-52
pubmed: 12512706
J Nucl Med. 2018 Jan;59(1):154-160
pubmed: 28887400
J Nucl Med. 2009 Mar;50(3):477-84
pubmed: 19258258
Ann ICRP. 2016 Nov;45(2):5-73
pubmed: 29749258
Ann ICRP. 2009;39(2):1-164
pubmed: 19897132
Ann ICRP. 2002;32(3-4):5-265
pubmed: 14506981
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
J Nucl Med. 2009 Feb;50(2):316-23
pubmed: 19164237
Ann ICRP. 2015 Jul;44(2 Suppl):7-321
pubmed: 26069086

Auteurs

Maxime Chauvin (M)

CRCT, UMR 1037, Inserm, Université Toulouse III Paul Sabatier, Toulouse, France.

Damian Borys (D)

Department of Systems Biology and Engineering, Silesian University of Technology, Gliwice, Poland.

Francesca Botta (F)

Medical Physics Unit, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Pawel Bzowski (P)

Department of Systems Biology and Engineering, Silesian University of Technology, Gliwice, Poland.

Jérémie Dabin (J)

SCK-CEN, Belgian Nuclear Research Centre, Mol, Belgium.

Ana M Denis-Bacelar (AM)

National Physical Laboratory, Teddington, United Kingdom.

Aurélie Desbrée (A)

Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Fontenay-aux-Roses, France.

Nadia Falzone (N)

MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United, Kingdom.
GenesisCare, Sydney, New South Wales, Australia.

Boon Quan Lee (BQ)

MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United, Kingdom.
GenesisCare, Sydney, New South Wales, Australia.

Andrea Mairani (A)

Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Medical Physics, National Centre of Oncological Hadrontherapy (CNAO), Pavia, Italy.

Alessandra Malaroda (A)

School of Physics and CMRP, University of Wollongong, Wollongong, New South Wales, Australia.
Theranostic and Nuclear Medicine Department, St. Vincent's Public Hospital, Sydney, New South Wales, Australia.

Gilles Mathieu (G)

Département du Système d'Information, Inserm, Paris, France.

Erin McKay (E)

St. George Hospital, Sydney, New South Wales, Australia.

Erick Mora-Ramirez (E)

CRCT, UMR 1037, Inserm, Université Toulouse III Paul Sabatier, Toulouse, France.
CICANUM, Escuela de Física, Universidad de Costa Rica, San Jose, Costa Rica.

Andrew P Robinson (AP)

National Physical Laboratory, Teddington, United Kingdom.
Schuster Laboratory, School of Physics and Astronomy, University of Manchester, Manchester, United Kingdom; and.
The Christie NHS Foundation Trust, Manchester, United Kingdom.

Lara Struelens (L)

SCK-CEN, Belgian Nuclear Research Centre, Mol, Belgium.

Alex Vergara Gil (AV)

CRCT, UMR 1037, Inserm, Université Toulouse III Paul Sabatier, Toulouse, France.

Manuel Bardiès (M)

CRCT, UMR 1037, Inserm, Université Toulouse III Paul Sabatier, Toulouse, France manuel.bardies@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH